FDA clears Symphonix Devices Vibrant Soundbridge:
This article was originally published in Clinica
Executive Summary
The US FDA has approved Symphonix Devices' PMA supplement for its next generation Vibrant Soundbridge semi-implantable hearing device. The system incorporates eight-channel digital signal processing (DSP) technology, which is housed in the external part of the device allowing Vibrant Soundbridge patients to upgrade their existing system. The San Jose, California company licensed the DSP technology from Siemens and will now programme its Vibrant Soundbridge using Siemens' PC-based Connexx fitting software. The device was CE-marked for sale in Europe last year.
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.